Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
Green360 Technologies Limited
ACN 140 316 463
Notice of General Meeting
The General Meeting of the Company will be held as follows:
Time and date: 10am (AWST) on Wednesday, 27 May 2026
In-person: Level 11, 40 The Esplanade, Perth, Western Australia 6000
The Notice of General Meeting should be read in its entirety. If Shareholders are in doubt as to
how to vote, they should seek advice from their suitably qualified advisor prior to voting.
Should you wish to discuss any matter, please do not hesitate to contact the Joint
Company Secretary by telephone on +61 8 6268 2641.
Shareholders are urged to vote by lodging the Proxy Form
Page 2
Green360 Technologies Limited
ACN 140 316 463
(Company)
Notice of General Meeting
Notice is hereby given that the general meeting of Shareholders of Green360 Technologies Limited ACN 140
316 463 will be held at Level 11, 40 The Esplanade, Perth, Western Australia 6000 on Wednesday, 27 May
2026 at 10am (AWST) (Meeting).
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that
the persons eligible to vote at the Meeting are those who are registered as Shareholders on Monday, 25 May
2026 at 5pm (AWST).
The Explanatory Memorandum provides additional information on matters to be considered at the Meeting.
The Explanatory Memorandum and the Proxy Form form part of the Notice.
Terms and abbreviations used in the Notice are defined in Schedule 1.
Agenda
1 Resolutions
Resolution 1 – Ratification of prior issue of Placement Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 111,500,000 Placement Shares under Listing Rule 7.1 on the terms and conditions
in the Explanatory Memorandum.’
Resolution 2 – Approval to issue Director Placement Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 10.11 and for all other purposes, Shareholders
approve the issue of up to 1,000,000 Director Placement Shares to Nicholas Anderson (or his
nominees) on the terms and conditions in the Explanatory Memorandum.’
Resolution 3 – Ratification of prior issue of Loan Conversion Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 20,000,000 Loan Conversion Shares to Tember Nominees under Listing Rule 7.1 on
Page 3
the terms and conditions in the Explanatory Memorandum.’
Resolution 4 – Approval to issue Director Appointment Performance Rights
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 10.14 and for all other purposes, Shareholders
approve the issue of up to 3,000,000 Director Appointment Performance Rights to Nicholas Anderson
(or his nominees) under the Plan, on the terms and conditions in the Explanatory Memorandum.’
Resolution 5 – Approval to issue Incentive Performance Rights
To consider and, if thought fit, to pass, with or without amendment, each as a separate ordinary
resolution, the following:
‘That, pursuant to and in accordance with Listing Rule 10.14, sections 195(4) and 208 of the
Corporations Act and for all other purposes, Shareholders approve the issue of up to 52,000,000
Incentive Performance Rights to the Directors (or their respective nominees) under the Plan as
follows:
(a) up to 40,000,000 Incentive Performance Rights to Aaron Banks;
(b) up to 3,000,000 Incentive Performance Rights to Peter Trinder;
(c) up to 3,000,000 Incentive Performance Rights to Nicholas Anderson,
(d) up to 3,000,000 Incentive Performance Rights to Darren Hedley; and
(e) up to 3,000,000 Incentive Performance Rights to Mark Pensabene;
on the terms and conditions in the Explanatory Memorandum.’
Voting exclusions
Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of:
(a) Resolution 1: by or on behalf of any person who participated in the issue of these Placement
Shares or is a counterparty to the agreement being approved, or any of their respective
associates;
(b) Resolution 2: by or on behalf of Nicholas Anderson (or his nominees), and any other person
who will obtain a material benefit as a result of the issue of these Director Placement Shares,
or any of his associates;
(c) Resolution 3: by or on behalf of Tember Nominees, and any other person who participated in
the issue of the Loan Conversion Shares, or any of their respective associates;
(d) Resolution 4: by or on behalf of Nicholas Anderson (or his nominees), and any person
referred to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan,
or any of their respective associates;
Page 4
(e) Resolution 5(a): by or on behalf of Aaron Banks (or his nominees), and any person referred
to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan, or any of
their respective associates;
(f) Resolution 5(b): by or on behalf of Peter Trinder (or his nominees), and any person referred
to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan, or any of
their respective associates;
(g) Resolution 5(c): by or on behalf of Nicholas Anderson (or his nominees), and any person
referred to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan,
or any of their respective associates;
(h) Resolution 5(d): by or on behalf of Darren Hedley (or his nominees), and any person referred
to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan, or any of
their respective associates; and
(i) Resolution 5(e): by or on behalf of Mark Pensabene (or his nominees), and any person
referred to in Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Plan,
or any of their respective associates.
The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote, in accordance with
directions given to the proxy or attorney to vote on the Resolution in that way;
(b) the Chair as proxy or attorney for a person who is entitled to vote, in accordance with a
direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on
the Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Voting prohibitions
Resolution 4 and Resolution 5(a) to (e) (inclusive): In accordance with section 250BD of the
Corporations Act, a person appointed as a proxy must not vote, on the basis of that appointment, on
the relevant Resolution if:
(a) the proxy is either a member of the Key Management Personnel or a Closely Related Party of
such member; and
(b) the appointment does not specify the way the proxy is to vote on the Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
Page 5
(b) the appointment expressly authorises the Chair to exercise the proxy even though the
Resolution is connected directly or indirectly with remuneration of a member of the Key
Management Personnel.
Further, in accordance with section 224 of the Corporations Act, a vote on Resolution 5(a) to (e)
(inclusive) must not be cast (in any capacity) by or on behalf of a related party of the Company to whom
the relevant Resolution would permit a financial benefit to be given, or an associate of such a related
party.
However, the above prohibition does not apply if:
(a) it is cast by a person as a proxy appointed by writing that specifies how the proxy is to vote on
the relevant Resolution; and
(b) it is not cast on behalf of a related party of the Company to whom the relevant Resolution would
permit a financial benefit to be given, or an associate of such a related party.
Please note: If the Chair is a person referred to in the section 224 Corporations Act voting prohibition
statement above, the Chair will only be able to cast a vote as proxy for a person who is entitled to vote
if the Chair is appointed as proxy in writing and the Proxy Form specifies how the proxy is to vote on
the relevant Resolution.
If you purport to cast a vote other than as permitted above, that vote will be disregarded by the Company
(as indicated above) and you may be liable for breaching the voting restrictions that apply to you under
the Corporations Act.
BY ORDER OF THE BOARD
Andrew Taylor
Joint Company Secretary
Green360 Technologies Limited
Dated: 13 April 2026
Page 6
Green360 Technologies Limited
ACN 140 316 463
(Company)
Explanatory Memorandum
1. Introduction
The Explanatory Memorandum has been prepared for the information of Shareholders in
connection with the business to be conducted at the Meeting to be held at Level 11, 40 The
Esplanade, Perth, Western Australia 6000 on Wednesday, 27 May 2026 at 10am (AWST)
(Meeting).
The Explanatory Memorandum forms part of the Notice which should be read in its entirety.
The Explanatory Memorandum contains the terms and conditions on which the Resolution will
be voted.
The Explanatory Memorandum includes the following information to assist Shareholders in
deciding how to vote on the Resolution:
Section 2 Action to be taken by Shareholders
Section 3 Resolution 1 – Ratification of prior issue of Placement Shares
Section 4 Resolution 2 – Approval to issue Director Placement Shares
Section 5 Resolution 3 – Ratification of prior issue of Loan Conversion Shares
Section 6 Resolution 4 – Approval to issue Director Appointment Performance Rights
Section 7 Resolution 5 – Approval to issue Incentive Performance Rights
Schedule 1 Definitions
Schedule 2 Summary of material terms of the Plan
Schedule 3 Terms and conditions of Director Appointment Performance Rights
Schedule 4 Valuation of Director Appointment Performance Rights
Schedule 5 Terms and conditions of Incentive Performance Rights
Schedule 6 Valuation of Incentive Performance Rights
A Proxy Form is located at the end of the Explanatory Memorandum.
2. Action to be taken by Shareholders
Shareholders should read the Notice including the Explanatory Memorandum carefully before
deciding how to vote on the Resolutions.
Page 7
2.1 Voting in person
To vote in person, attend the Meeting on the date and at the place set out above.
2.2 Voting by proxy
A Proxy Form is made available with this Notice. This is to be used by Shareholders if they
wish to appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited
and encouraged to attend the Meeting or, if they are unable to attend in person, sign and
return the Proxy Form to the Company in accordance with the instructions thereon.
Lodgement of a Proxy Form will not preclude a Shareholder from attending and voting at the
Meeting in person.
Please note that:
(a) a member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy;
(b) a proxy need not be a member of the Company; and
(c) a member of the Company entitled to cast two or more votes may appoint two proxies
and may specify the proportion or number of votes each proxy is appointed to
exercise, but where the proportion or number is not specified, each proxy may
exercise half of the votes.
The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy
Forms.
Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify
the way the proxy is to vote on a particular resolution and, if it does:
(a) the proxy need not vote on a show of hands, but if the proxy does so, the proxy must
vote that way (i.e. as directed);
(b) if the proxy has 2 or more appointments that specify different ways to vote on the
resolution – the proxy must not vote on a show of hands;
(c) if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
must vote on a poll, and must vote that way (i.e. as directed); and
(d) if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does
so, the proxy must vote that way (i.e. as directed).
Section 250BC of the Corporations Act provides that, if:
(a) an appointment of a proxy specifies the way the proxy is to vote on a particular
resolution at a meeting of the Company's members;
(b) the appointed proxy is not the chair of the meeting;
(c) at the meeting, a poll is duly demanded, or is otherwise required under section 250JA
on the resolution; and
(d) either the proxy is not recorded as attending the meeting or the proxy does not vote on
the resolution,
Page 8
the Chair of the meeting is taken, before voting on the resolution closes, to have been
appointed as the proxy for the purposes of voting on the resolution at the meeting.
Your proxy voting instruction must be received by 10am (AWST) on Monday 25 May 2026, being
not later than 48 hours before the commencement of the Meeting.
2.3 Chair's voting intentions
The Chair intends to exercise all available proxies in favour of all Resolutions, unless the
Shareholder has expressly indicated a different voting intention.
Subject to the following paragraph, if the Chair is your proxy, either by appointment or by default,
and you have not indicated your voting intention, you expressly authorise the Chair to exercise
the proxy in respect of Resolution 4 and Resolution 5(a) to (e) (inclusive) even though these
Resolutions are connected directly or indirectly with the remuneration of the Company’s Key
Management Personnel.
If the Chair is a person referred to in the voting prohibition statement applicable to a Resolution
(under section 224 of the Corporations Act), the Chair will only be able to cast a vote as proxy
for you on the relevant Resolution if you are entitled to vote and have specified your voting
intention in the Proxy Form.
2.4 Submitting questions
Shareholders may submit questions in advance of the Meeting to the Company. Questions
must be submitted by emailing the Joint Company Secretary at info@g360tech.au by no later
than five business days before the Meeting.
Shareholders will also have the opportunity to submit questions during the Meeting in respect
to the formal items of business. In order to ask a question during the Meeting, please follow
the instructions from the Chair.
The Chair will attempt to respond to the questions during the Meeting. The Chair will request
prior to a Shareholder asking a question that they identify themselves (including the entity
name of their shareholding and the number of Shares they hold).
3. Resolution 1 – Ratification of prior issue of Placement Shares
3.1 General
On 6 March 2026, the Company announced that it had received binding commitments for a
$4.5 million (before costs) placement via the issue of up to 112,500,000 Shares (Placement
Shares) at an issue price of $0.04 per Placement Share (Placement).
The issue of 112,500,000 Placement Shares is comprised of the following:
(a) 111,500,000 Placement Shares to non-related parties, which were issued on 13 March
2026 utilising the Company’s available placement capacity under Listing Rule 7.1 (the
subject of Resolution 1); and
(b) 1,000,000 Placement Shares (Director Placement Shares) to Non-Executive Director
Nicholas Anderson (or his nominees) subject to Shareholder approval under Listing
Rule 10.11 (the subject of Resolution 2).
Page 9
Resolution 1 seeks the approval of Shareholders pursuant to Listing Rule 7.4 to ratify the issue
of 111,500,000 Placement Shares under Listing Rule 7.1.
3.2 Listing Rules 7.1 and 7.4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of
Equity Securities that a listed company can issue without the approval of its shareholders over
any 12-month period to 15% of the fully paid ordinary shares it had on issue at the start of that
period.
Listing Rule 7.4 provides an exception to Listing Rules 7.1. It provides that where a company in
a general meeting ratifies the previous issue of securities made pursuant to Listing Rule 7.1
(and provided that the previous issue did not breach Listing Rule 7.1), those securities will be
deemed to have been made with shareholder approval for the purposes of Listing Rule 7.1.
The effect of Shareholders passing Resolution 1 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 1 is passed, 111,500,000 Placement Shares will be excluded in calculating the
Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of Equity Securities
it can issue without Shareholder approval over the 12-month period following the issue date.
If Resolution 1 is not passed, 111,500,000 Placement Shares will continue to be included in the
Company’s 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity
Securities the Company can issue or agree to issue without obtaining prior Shareholder
approval, to the extent of 111,500,000 Equity Securities for the 12-month period following the
issue of those Placement Shares.
The Company confirms that Listing Rule 7.1 was not breached at the time the Placement Shares
were issued.
3.3 Specific information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in
relation to the ratification of the issue of 111,500,000 Placement Shares:
(a) These Placement Shares were issued to new and existing professional and
sophisticated investors, none of whom are a related party of the Company or a
Material Investor (based on information known to the Company) (Placement
Participants). The Placement Participants were identified through a bookbuild
process, which involved the Company and CPS Capital Group Pty Ltd (Lead
Manager) seeking expressions of interest to participate in the Placement from new
and existing contacts of the Company and Lead Manager.
(b) A total of 111,500,000 Placement Shares were issued under Listing Rule 7.1.
(c) The Placement Shares are fully paid and rank equally in all respects with the Company’s
existing Shares on issue.
(d) The Placement Shares were issued on 13 March 2026 at an issue price of $0.04 each,
raising $4,460,000 (before costs).
(e) Proceeds of the Placement have been and are intended to be strategically deployed to
support key growth and commercialisation initiatives across the Company’s business,
such as:
Page 10
(i) capital expenditure and operating costs associated with the anticipated
commercialisation of Eco-Clay;
(ii) development of further low-carbon cement formulations;
(iii) Pittong operations working capital; and
(iv) general working capital and costs associated with the Placement.
(f) There are no other material terms to the agreement for the subscription of the
Placement Shares.
(g) A voting exclusion statement is included in the Notice.
3.4 Additional information
Resolution 1 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 1.
4. Resolution 2 – Approval to issue Director Placement Shares
4.1 General
The background to the Placement, including the proposed issue of Director Placement Shares
is set out in Section 3.1 above.
Resolution 2 seeks the approval of Shareholders pursuant to Listing Rule 10.11 for the issue of
1,000,000 Director Placement Shares to Nicholas Anderson (or his nominees).
4.2 Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company must not issue or agree to issue Equity Securities to any of the following persons
without the approval of Shareholders:
(a) a related party (Listing Rule 10.11.1);
(b) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (30%+) in the company (Listing Rule 10.11.2);
(c) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (10%+) in the company and who has nominated a director to the
board of the company pursuant to a relevant agreement which gives them a right or
expectation to do so (Listing Rule 10.11.3);
(d) an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing
Rule 10.11.4); or
(e) a person whose relationship with the company or a person referred to in Listing
Rules 10.11.1 or 10.11.4 is such that, in ASX’s opinion, the issue or agreement should
be approved by its shareholders (Listing Rule 10.11.5).
Nicholas Anderson is a related party of the Company by virtue of being a director of the
Page 11
Company.
Shareholder approval pursuant to Listing Rule 10.11 is therefore required unless an exception
applies. It is the view of the Board that the exceptions set out in Listing Rule 10.12 do not apply
in the current circumstances.
Approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Placement
Shares as approval is being obtained under Listing Rule 10.11. Accordingly, the issue of the
Director Placement Shares to Nicholas Anderson (or his nominees) will not be included in the
Company’s 15% placement capacity pursuant to Listing Rule 7.1.
The effect of Shareholders passing Resolution 2 will be to allow the Company to issue the
Director Placement Shares, raising $40,000 (before costs) under the Placement.
If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the
Director Placement Shares and will not raise $40,000 (before costs).
4.3 Specific information required by Listing Rule 10.13
Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in
relation to the proposed issue of the Director Placement Shares:
(a) A maximum of 1,000,000 Director Placement Shares will be issued to Nicholas
Anderson (or his nominees).
(b) Nicholas Anderson falls into the category stipulated by Listing Rule 10.11.1. In the event
the Director Placement Shares are issued to a nominee of Mr Anderson, that nominee
will fall into the category stipulated by Listing Rule 10.11.4.
(c) The Director Placement Shares will be fully paid and rank equally in all respects with
the Company’s existing Shares on issue.
(d) The Director Placement Shares will be issued no later than 1 month after the date of
the Meeting.
(e) The Director Placement Shares will be issued at an issue price of $0.04 each, being the
same price as those Placement Shares issued to non-related party participants in the
Placement.
(f) A summary of the intended use of funds raised from the Placement is set out in
Section 3.1 above.
(g) The proposed issue of the Director Placement Shares is not intended to remunerate or
incentivise Nicholas Anderson.
(h) There are no other material terms to the proposed issue of the Director Placement
Shares.
(i) A voting exclusion statement is included in the Notice.
4.4 Chapter 2E of the Corporations Act
In accordance with Chapter 2E of the Corporations Act, in order to give a financial benefit to a
related party, the Company must:
(a) obtain Shareholder approval in the manner set out in sections 217 to 227 of the
Page 12
Corporations Act;
(b) give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to 216
of the Corporations Act.
The proposed issue of the Director Placement Shares constitutes giving a financial benefit to a
related party of the Company.
The Board (with Mr Anderson abstaining) considers that Shareholder approval pursuant to
Chapter 2E of the Corporations Act is not required in respect of the issue of the Director
Placement Shares because the Director Placement Shares will be issued on the same terms
as those Placement Shares issued to non-related party participants in the Placement and as
such the giving of the financial benefit is on arm’s length terms.
4.5 Additional information
Resolution 2 is an ordinary resolution.
The Board (with Mr Anderson abstaining due to his personal interest in the outcome of the
Resolution) recommends Shareholders vote in favour of Resolution 2.
5. Resolution 3 – Ratification of prior issue of Loan Conversion Shares
5.1 General
On 30 November 2023, the Company announced that it secured $1 million in debt funding, from
private lender Tember Nominees, using its non-core asset, being freehold land it owns at Lal
Lal, located in Victoria, as security against the loan (Mortgage Loan).
In November 2025, the Company and Tember Nominees agreed to:
(a) convert half the Mortgage Loan to equity via the issue of 20,000,000 Shares at a
deemed issue price of $0.025 per Share (Loan Conversion Shares); and
(b) extend the repayment of the remaining Mortgage Loan of $500,000 for a further six-
month period ending 29 May 2026, with the interest rate for this period being 11% per
annum. As partial consideration for the extension, the Company issued Tember
Nominees 500,000 Options exercisable at $0.06 each and expiring on 27 November
2027.
The Company issued the Loan Conversion Shares to Tember Nominees on 27 November 2025
utilising its available placement capacity under Listing Rule 7.1.
Resolution 3 seeks the approval of Shareholders pursuant to Listing Rule 7.4 to ratify the issue
of the Loan Conversion Shares under Listing Rule 7.1.
5.2 Listing Rules 7.1 and 7.4
A summary of Listing Rules 7.1 and 7.4 is set out in Section 3.2 above.
The effect of Shareholders passing Resolution 3 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
Page 13
If Resolution 3 is passed, 20,000,000 Loan Conversion Shares will be excluded in calculating
the Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of Equity
Securities it can issue without Shareholder approval over the 12-month period following the
issue date.
If Resolution 3 is not passed, 20,000,000 Loan Conversion Shares will continue to be included
in the Company’s 15% limit under Listing Rule 7.1, effectively decreasing the number of Equity
Securities the Company can issue or agree to issue without obtaining prior Shareholder
approval, to the extent of 20,000,000 Equity Securities for the 12-month period following the
issue of the Loan Conversion Shares.
The Company confirms that Listing Rule 7.1 was not breached at the time the Loan Conversion
Shares were issued.
5.3 Specific information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in
relation to the ratification of the issue of the Loan Conversion Shares:
(a) The Loan Conversion Shares were issued to Tember Nominees, whom is not a related
party of the Company.
(b) A total of 20,000,000 Loan Conversion Shares were issued under Listing Rule 7.1.
(c) The Loan Conversion Shares are fully paid and rank equally in all respects with the
Company’s existing Shares on issue.
(d) The Loan Conversion Shares were issued on 27 November 2025 at a deemed issue
price of $0.025 each.
(e) The Loan Conversion Shares were issued for nil cash consideration as they were issued
in lieu of cash for half of the Mortgage Loan. Accordingly, no funds were raised from the
issue of the Loan Conversion Shares.
(f) There are no other materials terms to the agreement for the issue of the Loan
Conversion Shares.
(g) A voting exclusion statement is included in the Notice.
5.4 Additional information
Resolution 3 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 3.
Page 14
6. Resolution 4 – Approval to issue Director Appointment Performance
Rights
6.1 General
On 16 December 2025, the Company announced that it had appointed Nicholas Anderson as
Non-Executive Director effective 1 January 2026.
As part of Mr Anderson’s appointment, the Company agreed, subject to obtaining Shareholder
approval, to issue up to a total of 3,000,000 Performance Rights to Nicholas Anderson, or his
nominees, under the Plan (Director Appointment Performance Rights) as follows:
Director
Director Appointment Performance Rights
Total
Tranche A(1)
Tranche B(2)
Tranche C(3)
Nicholas
Anderson
1,000,000 1,000,000 1,000,000 3,000,000
Notes:
1. Vesting upon the VWAP of Shares as traded on the ASX, equalling or exceeding $0.065 per Share,
calculated over 20 consecutive trading days on which the Company’s shares have actually traded.
2. Vesting upon the VWAP of Shares as traded on the ASX, equalling or exceeding $0.08 per Share,
calculated over 20 consecutive trading days on which the Company’s shares have actually traded.
3. Vesting upon the VWAP of Shares as traded on the ASX, equalling or exceeding $0.095 per Share,
calculated over 20 consecutive trading days on which the Company’s shares have actually traded.
The Director Appointment Performance Rights are to be issued under the Plan on the terms
and conditions in Schedule 3. A summary of the material terms of the Plan is in Schedule 2.
Resolution 4 seeks Shareholder approval pursuant to Listing Rule 10.14 for the issue of the
Director Appointment Performance Rights to Nicholas Anderson (or his nominees) under the
Plan.
6.2 Listing Rule 10.14
Listing Rule 10.14 provides that an enti
Share your feedback
Discover